Examination Report |
1 | Additional Representation Sheet | 24 Jan 2017 |
2 | TM-1 | 24 Jan 2017 |
3 | Power of Attorney | 24 Jan 2017 |
4 | Reply to Exam Report (MIS-R) | 07 Mar 2017 |
5 | Reply to Exam Report (MIS-R) | 26 Oct 2018 |
6 | Reply to Exam Report (MIS-R) | 26 Oct 2018 |
7 | Power of Attorney | 07 Feb 2019 |
8 | TM-O(NOTICE OF OPPOSITION) | 21 Apr 2019 |
9 | Journal Copy | 10 May 2019 |
1 | Hearing Notice (Show Cause) | 7506005 | 3683097 | 21 Dec 2018 |
2 | Tribunal Accepted Notice for : 3464721 | 7745636 | 3756090 | 07 Feb 2019 |
3 | Opposition Notice | 8413427 | 4149620 | 12 Jun 2019 |
4 | Order Form of 21(2) | 9339284 | 4584424 | 02 Dec 2019 |
The application for Glypten-m 1000 mg. was made on 24 January 2017.
The trademark applicant for Glypten-m 1000 mg. is FRANCOINDIAN PHARMACEUTICALS.
Glypten-m 1000 mg. is applied in class(es) 5.
Application for Glypten-m 1000 mg. is on Abandoned stage.
Application Id allotted to Glypten-m 1000 mg. is 3464721.
Glypten-m 1000 mg. filed with the Intellectual property office as a WORD.